|

LUTATHERA® by intra-arterial hepatic (IAH) injection Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • University Hospital, Bordeaux1

Indications

  • Neuroendocrine Gastroenteropancreatic Tumour1
  • Neuroendocrine Tumor1
  • Liver Metastases1
  • Liver Cancer1
  • Cancer1

Other1 trial

Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.